Study of Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With an Allergy to Peanuts
Public ClinicalTrials.gov record NCT05432388. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A One Month, Investigator and Participant Blinded Study to Investigate the Efficacy and Safety of Remibrutinib (LOU064) at Multiple Dose Levels in Adult Participants With Peanut Allergy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A study to evaluate the safety, efficacy and tolerability of remibrutinib at three doses versus placebo in adult participants who have a confirmed allergy to peanuts. The efficacy was measured by the ability of participants to tolerate increasing doses of peanut protein during an oral food challenge after 1 month of study treatment.
Study identification
- NCT ID
- NCT05432388
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 76 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 12, 2022 (Actual)
- Primary completion
- Mar 11, 2025 (Actual)
- Completion
- Mar 11, 2025 (Actual)
- Last update posted
- Jun 12, 2026
2022 – 2025
United States locations
- U.S. sites
- 24
- U.S. states
- 17
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Allervie Clinical Research | Birmingham | Alabama | 35209 | — |
| Arkansas Children's Hospital | Little Rock | Arkansas | 72202 | — |
| California Allergy and Asthma Medical Group | Los Angeles | California | 90025 | — |
| Allergy and Asthma Clin Res Inc | Walnut Creek | California | 94598 | — |
| Asthma and Allergy Associates P C | Colorado Springs | Colorado | 80907 | — |
| Colorado Allergy and Asthma Ctr PC | Denver | Colorado | 80230 | — |
| Childrens National Hospital | Washington D.C. | District of Columbia | 20010 | — |
| Treasure Valley Medical Research | Boise | Idaho | 83706 | — |
| Midwest Allergy Sinus Asthma SC | Normal | Illinois | 61761 | — |
| Asthma and Allergy Center of Chicago S C | River Forest | Illinois | 60305 | — |
| Bluegrass Allergy Research . | Lexington | Kentucky | 40509 | — |
| Bluegrass Allergy Research | Lexington | Kentucky | 40509 | — |
| Family Allergy and Asthma | Louisville | Kentucky | 40217 | — |
| Johns Hopkins Hospital | Baltimore | Maryland | 21287 | — |
| Institute for Asthma and Allergy PC | Chevy Chase | Maryland | 20815 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| University of Michigan Clinical Trials Office | Ann Arbor | Michigan | 48109 | — |
| CenExel HRI | Berlin | New Jersey | 08009 | — |
| CR Services Acquisition US Main center | Columbus | Ohio | 43213 | — |
| CR Services Acquisition US | Columbus | Ohio | 43213 | — |
| Vital Prospects Clinical Research Institute | Tulsa | Oklahoma | 74136 | — |
| Western Sky Medical Research | El Paso | Texas | 79924 | — |
| Allergy Associates of Utah | Sandy City | Utah | 84093 | — |
| Seattle Allergy and Asthma Rsch | Seattle | Washington | 98115 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05432388, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 12, 2026 · Synced Nov 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05432388 live on ClinicalTrials.gov.